Potential endocrine disrupting effect of ochratoxin A on human placental 3β-hydroxysteroid dehydrogenase/isomerase in JEG-3 cells at levels relevant to human exposure

Reproductive Toxicology

Volumn 38, Issue , 2013, Pages 47-52

  Woo, Chit Shing Jackson ^a   Wan, Murphy Lam Yim ^a   Ahokas, Jorma ^b   El Nezami, Hani ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b RMIT UNIVERSITY   (Australia)

Author keywords

3 Hydroxysteroid dehydrogenase isomerase; Endocrine disruptor; JEG 3; Ochratoxin A; Placenta; Steroidogenesis

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ENDOCRINE DISRUPTOR; MESSENGER RNA; OCHRATOXIN; PROGESTERONE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF HORMONE METABOLISM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LONG TERM EXPOSURE; PLACENTA; PROGESTERONE RELEASE; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; SHORT TERM EXPOSURE;

17-HYDROXYSTEROID DEHYDROGENASES; CELL LINE, TUMOR; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; OCHRATOXINS; PLACENTA; PREGNANCY; PROGESTERONE; RNA, MESSENGER;

RATTUS;

EID: 84875801646     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.02.034     Document Type: Article

References (36)

1. Pitt J.I. Toxigenic fungi and mycotoxins. British Medical Bulletin 2000, 56:184-192.
2. O'Brien E., Dietrich D.R. Ochratoxin A: the continuing enigma. Critical Reviews in Toxicology 2005, 35:33-60.
3. Wangikar P.B., Sinha N., Dwivedi P., Sharma A.K. Teratogenic effects of ochratoxin A and aflatoxin B1 alone and in combination on post-implantation rat embryos in culture. Journal of the Turkish-German Gynecological Association 2007, 8:357-366.
4. Gupta M., Bandyopadhyay S., Mazumdar S.K., Paul B. Ovarian steroidogenesis in rats following ochratoxin A treatment. Toxicology and Applied Pharmacology 1980, 53:515-520.
5. Fenske M., Fink-Gremmels J. Effects of fungal metabolites on testosterone secretion in vitro. Archives of Toxicology 1990, 64:72-75.
6. Shashi N.K., Avinash G.T., Karan P.S., Arun K.J., Masarrat A., Rajendra D.P. Experimentally induced toxicity of ochratoxin A and endosulfan in male Wistar rats: a hormonal disorder. Journal of Animal and Veterinary Advances 2011, 10:1750-1755.
7. Hassan A.A., Rashid M.A., Koratum K.M. Effect of aflatoxin B1, zearalenone and ochratoxin A on some hormones related to fertility in male rats. Life Science Journal 2010, 7:64-72.
8. Thomas J.L., Myers R.P., Strickler R.C. Human placental 3[beta]-hydroxy-5-ene-steroid dehydrogenase and steroid 5→4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes. Journal of Steroid Biochemistry 1989, 33:209-217.
9. Labrie F., Simard J., Luu-The V., Pelletier G., Bélanger A., Lachance Y., et al. Structure and tissue-specific expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues. Journal of Steroid Biochemistry and Molecular Biology 1992, 41:421-435.
10. Rhéaume E., Lachance Y., Zhao H-F., Breton N., Dumont M., Launoit Y.d., et al. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase in human adrenals and gonads. Molecular Endocrinology 1991, 5:1147-1157.
11. Ferre F., Breuiller M., Cedard L. Human placental delta5-3beta hydroxysteroid dehydrogenase activity (delta5-3beta HSDH): intracellular distribution, kinetic properties, retroinhibition and influence of membrane delipidation. Steroids 1975, 26:551-570.
12. McAllister J.M., Hornsby P.J. Dual regulation of 3 beta-hydroxysteroid dehydrogenase, 17 alpha-hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3',5'-monophosphate and activators of protein kinase C in cultured human adrenocortical cells. Endocrinology 1988, 122:2012-2018.
13. Dumont M., Luu-The V., Dupont E., Pelletier G., Labrie F. Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. Journal of Investigative Dermatology 1992, 99:415-421.
14. Gingras S., Moriggl R., Groner B., Simard J. Induction of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13. Molecular Endocrinology 1999, 13:66-81.
15. Lacoste D., Bélanger A., Labrie F. Biosynthesis and degradation of androgens in human prostatic cancer cell lines. Annals of the New York Academy of Sciences 1990, 595:389-391.
16. Mason J.I., Ushijima K., Doody K.M., Nagai K., Naville D., Head J.R., et al. Regulation of expression of the 3 beta-hydroxysteroid dehydrogenases of human placenta and fetal adrenal. Journal of Steroid Biochemistry and Molecular Biology 1993, 47:151-159.
17. Kacsoh B. Endocrine physiology 2000, The McGraw-Hill Companies, Inc., USA.
18. Samson M., Labrie F., Luu-The V. Specific estradiol biosynthetic pathway in choriocarcinoma (JEG-3) cell line. Journal of Steroid Biochemistry and Molecular Biology 2009, 116:154-159.
19. JECFA Ochratoxin A. (Addendum) WHO Food Additive Series 59: safety evaluation of certain food additives and contaminants 2008, IPCS, WHO, Geneva, p. 357-429.
20. Tremblay Y., Beaudoin C. Regulation of 3 beta-hydroxysteroid dehydrogenase and 17 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3',5'-monophosphate and phorbol myristate acetate in human choriocarcinoma cells. Molecular Endocrinology 1993, 7:355-364.
21. Sullivan M.H. Endocrine cell lines from the placenta. Molecular and Cellular Endocrinology 2004, 228:103-119.
22. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative CT method. Nature Protocols 2008, 3:1101-1108.
23. Wu X., Iguchi T., Itoh N., Okamoto K., Takagi T., Tanaka K., et al. Ascorbic acid transported by sodium-dependent vitamin C transporter 2 stimulates steroidogenesis in human choriocarcinoma cells. Endocrinology 2008, 149:73-83.
24. Pongcharoen S., Supalap K. Interleukin-17 increased progesterone secretion by JEG-3 human choriocarcinoma cells. American Journal of Reproductive Immunology 2009, 61:261-264.
25. Debnath S., Mukherjee D., Bhattachryya S.P. Stimulation of pregnenolone metabolism and aromatase activity by luteinizing hormone in mouse uterus. European Journal of Endocrinology 2000, 143:799-807.
26. Mason J.I., Keeney D.S., Bird I.M., Rainey W.E., Morohashi K.-I., Leers-Sucheta S., et al. The regulation of 3[beta]-hydroxysteroid dehydrogenase expression. Steroids 1997, 62:164-168.
27. Payne A.H., Abbaszade I.G., Clarke T.R., Bain P.A., Park C.H. The multiple murine 3 beta-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression. Steroids 1997, 62:169-175.
28. LaVoie H.A., King S.R. Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Experimental Biology and Medicine 2009, 234:880-907.
29. Beaudoin C., Bonenfant M., Tremblay Y. Regulation of cytochrome P450 cholesterol side-chain cleavage, 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase type 1 and estradiol-17β-hydroxysteroid dehydrogenase mRNA levels by calcium in human choriocarcinoma JEG-3 cells. Molecular and Cellular Endocrinology 1997, 133:63-71.
30. Khan S., Martin M., Bartsch H., Rahimtula A.D. Perturbation of liver microsomal calcium homeostasis by ochratoxin A. Biochemical Pharmacology 1989, 38:67-72.
31. Benesic A., Mildenberger S., Gekle M. Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells. Pflügers Archiv European Journal of Physiology 2000, 439:278-287.
32. Bird I.M., Pasquarette M.M., Rainey W.E., Mason J.I. Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells. Journal of Clinical Endocrinology and Metabolism 1996, 81:2171-2178.
33. Rainey W.E., Bird I.M., Mason J.I. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Molecular and Cellular Endocrinology 1994, 100:45-50.
34. Gekle M., Sauvant C., Schwerdt G. Ochratoxin A at nanomolar concentrations: a signal modulator in renal cells. Molecular Nutrition and Food Research 2005, 49:118-130.
35. Metzler M., Pfeiffer E., Hildebrand A. Zearalenone and its metabolites as endocrine disrupting chemicals. World Mycotoxin Journal 2010, 3:385-401.
36. Storvik M., Huuskonen P., Kyllönen T., Lehtonen S., El-Nezami H., Auriola S., et al. Aflatoxin B1 - a potential endocrine disruptor - up-regulates CYP19A1 in JEG-3 cells. Toxicology Letters 2011, 202:161-167.